Código QR (código de barras bidimensional)

DARATUMUMAB (DARA), CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIFIED TREATMENT FOR TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TE NDMM) PATIENTS

Background: Newly drugs access for MM treatment still a challenge in some countries. One of the most availableinductions for TE NDMM patients (pts) worldwide is cyclophosphamide (C), thalidomide (T) and dexamethasone (d)-(CTd). Dara the first anti- CD38, had been combined with VCd, VTd and VRd and m...

ver descrição completa

Na minha lista:
Principais autores: EQ Crusoe, J Santos, J Leal, H Santos, A Almeida, L Lucas, M Chaves, V Hungria, M Salvino, MG Arruda
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021-10-01
coleção:Hematology, Transfusion and Cell Therapy
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2531137921004776
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados